Two stocks in Healthcare
Danaher vs Eli Lilly and Company: profit, growth, debt and price compared
Danaher is stronger on 4 of 7 figures: debt, price for its expected profit, dividend and analysts' view. Eli Lilly and Company is stronger on 3: profit margin, sales growth and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| DanaherDHR | Eli Lilly and CompanyLLY | |
|---|---|---|
| Net margin | 16.9% | Stronger: 31.9% |
| Revenue growth, past year | +8.28% | Stronger: +38.61% |
| Debt to equity | Stronger: 51.8% | 122.9% |
| Forward P/E | Stronger: 24.5× | 27.2× |
| Dividend yield | Stronger: 0.71% | 0.49% |
| Analysts | Stronger: Strong buy · 21 | Buy · 29 |
| From its 200-day average | +9.3% | Stronger: +21.2% |
Share price over the past year
- Danaher+1.4%
- Eli Lilly and Company+34.2%
18 Nov 202518 Nov 2026
Danaher or Eli Lilly and Company: which is stronger?
- LLY
Which is more profitable?
Eli Lilly and Company keeps more of each sale as profit: 31.9% against 16.9%.
- LLY
Which is growing its sales faster?
Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +8.28%.
- DHR
Which has borrowed less?
Danaher has borrowed less: its debt is 51.8% of what its shareholders own, against 122.9% for Eli Lilly and Company.
- DHR
Which costs less for the profit it is expected to make?
Danaher costs less for the profit it is expected to make: 24.5× its forward earnings, against 27.2×.
- DHR
Which pays more in dividends?
Danaher pays more back in dividends for what a share costs: 0.71% a year, against 0.49%.
- DHR
Which do analysts rate higher?
Analysts are warmer on Danaher: Strong buy, against Buy for Eli Lilly and Company.
- LLY
Which is in the stronger price trend?
Eli Lilly and Company's price is in the stronger trend: 21.2% above its 200-day average, against 9.3% above.
What each company does
DHRDanaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Reports results on 27 January 2027
LLYEli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
Reports results on 3 February 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.